Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Prevention of Alzheimer'S Disease
|
May 7, 2026
Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE<sub>4</sub> heterozygotes and non-carriers
Jemma Hazan, Kathy Y Liu, Robert Howard
The Journal of Prevention of Alzheimer'S Disease
|
February 21, 2026
Long-term extension data do not robustly support clinical disease course modification with donanemab
Jemma Hazan, Kathy Y Liu, Robert Howard
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 1, 2026
What should convince a clinician of disease modification in Alzheimer's disease clinical trials?
Jemma Hazan, Kathy Y Liu, Robert Howard
International Journal of Geriatric Psychiatry
|
July 2, 2026
England's Dementia Diagnosis Landscape: Strengths, Limitations, and Future Directions
Jemma Hazan, Robert Howard, Jeremy D Isaacs
BMJ Open Quality
|
March 10, 2022
Improving the handover process in a psychiatry liaison setting
Kirtana Vallabhaneni, Jemma Hazan, Lucinda Donaldson, et al.
Journal of Alzheimer'S Disease : JAD
|
May 30, 2023
Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process
Jemma Hazan, Kathy Y Liu, Nick Fox, et al.
International Journal of Geriatric Psychiatry
|
January 8, 2022
Practical application of Alzheimer's Disease Neuroimaging Initiative plasma P-tau181 reference data to support diagnosis of Alzheimer's disease
Jemma Hazan, Duncan Alston, Nick C Fox, et al.
Brain Communications
|
December 13, 2023
Online clinical tools to support the use of new plasma biomarker diagnostic technology in the assessment of Alzheimer's disease: a narrative review
Jemma Hazan, Kathy Y Liu, Nick C Fox, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 27, 2025
Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.
Aging & Mental Health
|
October 16, 2024
Dementia diagnosis rates and the impact of ethnicity, rurality and deprivation
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Prevention of Alzheimer'S Disease
|
May 7, 2026
Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE<sub>4</sub> heterozygotes and non-carriers
Jemma Hazan, Kathy Y Liu, Robert Howard
The Journal of Prevention of Alzheimer'S Disease
|
February 21, 2026
Long-term extension data do not robustly support clinical disease course modification with donanemab
Jemma Hazan, Kathy Y Liu, Robert Howard
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 1, 2026
What should convince a clinician of disease modification in Alzheimer's disease clinical trials?
Jemma Hazan, Kathy Y Liu, Robert Howard
International Journal of Geriatric Psychiatry
|
July 2, 2026
England's Dementia Diagnosis Landscape: Strengths, Limitations, and Future Directions
Jemma Hazan, Robert Howard, Jeremy D Isaacs
BMJ Open Quality
|
March 10, 2022
Improving the handover process in a psychiatry liaison setting
Kirtana Vallabhaneni, Jemma Hazan, Lucinda Donaldson, et al.
Journal of Alzheimer'S Disease : JAD
|
May 30, 2023
Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process
Jemma Hazan, Kathy Y Liu, Nick Fox, et al.
International Journal of Geriatric Psychiatry
|
January 8, 2022
Practical application of Alzheimer's Disease Neuroimaging Initiative plasma P-tau181 reference data to support diagnosis of Alzheimer's disease
Jemma Hazan, Duncan Alston, Nick C Fox, et al.
Brain Communications
|
December 13, 2023
Online clinical tools to support the use of new plasma biomarker diagnostic technology in the assessment of Alzheimer's disease: a narrative review
Jemma Hazan, Kathy Y Liu, Nick C Fox, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 27, 2025
Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.
Aging & Mental Health
|
October 16, 2024
Dementia diagnosis rates and the impact of ethnicity, rurality and deprivation
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.
Page
of 3